The ADSs of Scage Future (“Scage”), the combined company following the Business Combination, will begin trading on the Nasdaq on June 30, 2025, under the ticker symbol “SCAG.”BEIJING, June 27, 2025 (GLOBE NEWSWIRE) — Scage International Limited (“Scage International” or the “Company”), a zero-emission solution provider of new energy heavy-duty commercial vehicles and e-fuel solutions, and Finnovate Acquisition Corp (“Finnovate”) (OTC: FNVTF), a special purpose acquisition company, today announced the completion of their previously announced business combination (the “Business Combination”). The American depositary shares (“ADSs”) of the combined company, Scage Future, will commence trading on the Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “SCAG” on June 30, 2025. The Business Combination was approved by Finnovate’s...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) — Portman Ridge Finance Corporation (NASDAQ: PTMN) (“Portman Ridge” or “PTMN”) announced today that it obtained shareholder approval for the issuance of PTMN common stock in connection with the proposed merger of Logan Ridge Finance Corporation (NASDAQ: LRFC) (“Logan Ridge” or “LRFC”) with and into PTMN (the “Share Issuance Proposal”) following the adjourned special meeting of shareholders held on June 27, 2025. PTMN shareholders voted overwhelmingly in favor of the proposed transaction, with approximately 88% of voting shareholders supporting the proposal. Of note, on June 20, 2025, LRFC stockholders approved the merger with PTMN. Thus, subject to the satisfaction of customary closing conditions, the merger is expected to close on or about July 15, 2025. Ted Goldthorpe, President and Chief...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) — At a joint special meeting earlier today, common shareholders of each of PIMCO Municipal Income Fund II (NYSE: PML), PIMCO New York Municipal Income Fund II (NYSE: PNI) and PIMCO California Municipal Income Fund (NYSE: PCQ) (each, an “Acquiring Fund”) approved the issuance of additional common shares in connection with each of the below reorganizations, as applicable (each, a “Merger” and collectively, the “Mergers”):National Mergers: PIMCO Municipal Income Fund (NYSE: PMF) and PIMCO Municipal Income Fund III (NYSE: PMX) with and into PML; New York Mergers: PIMCO New York Municipal Income Fund (NYSE: PNF) and PIMCO New York Municipal Income Fund III (NYSE: PYN) with and into PNI; and California Mergers: PIMCO California Municipal Income Fund II (NYSE: PCK) and PIMCO California Municipal...

Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, June 27, 2025 (GLOBE NEWSWIRE) — DGL Investments No. 1 Inc. (“DGL” or the “Company”) (TSXV: DGL.P) announces that the Letter of Intent it had entered into with Rep Group Limited (“REP”) and Perspectives Productions Limited (“Perspectives” and collectively with REP, the “Targets”) as announced by News Release dated April 14, 2025 has been mutually terminated by the parties as of June 26, 2025. The parties made extensive attempts to secure financing for the proposed transaction, however it could not be agreed within a timeframe that met the parties’ expectations. As a result DGL is now actively seeking a business to acquire as its qualifying transaction. It is expected that the Company’s common shares...

VANCOUVER, British Columbia, June 27, 2025 (GLOBE NEWSWIRE) — Methanex Corporation (TSX:MX) (Nasdaq:MEOH) announced today that it has completed the previously announced acquisition of OCI Global’s (“OCI”) international methanol business. As part of the transaction, first announced in September 2024, Methanex has acquired an interest in i) two world-scale methanol facilities in Beaumont, Texas, which have access to robust North American natural gas feedstock and one of which also produces ammonia, ii) a low-carbon methanol production and marketing business, and iii) a currently idled methanol facility in the Netherlands. The transaction consideration consists of approximately $1.2 billion of cash, excluding adjustments to working capital and cash acquired, the issuance of approximately 9.9 million common shares of Methanex and the...

Embarks on a New Chapter of Growth and Innovation Atlanta, GA, June 27, 2025 (GLOBE NEWSWIRE) — GlassRatner Advisory & Capital Group, LLC (“GlassRatner”), a leading provider of specialty professional and advisory services has reestablished itself as an independent brand following its acquisition by TorQuest Partners from B. Riley Financial, Inc. earlier today.   With a 24-year legacy of delivering high-value financial advisory solutions, GlassRatner has built a reputation for excellence in Restructuring, Turnaround Management & Bankruptcy Consulting; Forensic Accounting & Litigation Support; and Transaction Support Services—such as Due Diligence and Quality of Earnings Reviews.  In recent years the firm has successfully expanded its reach into Engineering & Construction Consulting, Risk & Resilience Consulting...

Firm to Rebrand as GlassRatner and Positioned to Build & Grow an Independent Advisory Business in Canada Toronto, Canada, June 27, 2025 (GLOBE NEWSWIRE) — B. Riley Farber Advisory Inc. (“B. Riley Farber”) and GlassRatner Advisory & Capital Group, LLC (“GlassRatner”), leading providers of high-value financial advisory services, are pleased to announce their acquisition by Toronto-based private equity firm TorQuest Partners. The transaction marks a significant milestone for both firms as B. Riley Farber rebrands under the GlassRatner name across Canada, enhancing their collective capabilities and positioning them for accelerated growth. This acquisition includes B. Riley Farber’s entire Canadian team and operations, ensuring seamless continuity for clients while strengthening their collective capabilities in the Canadian...

All amounts are expressed in Canadian dollars unless otherwise indicated TORONTO, June 27, 2025 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) and Angus Gold Inc. (TSX-V: GUS, OTC: ANGVF) (“Angus”) are pleased to announce the successful acquisition by Wesdome of all of the issued and outstanding common shares of Angus not already owned by Wesdome pursuant to a plan of arrangement (the “Arrangement”). The Arrangement became effective as of today’s date, resulting in Angus becoming a wholly owned subsidiary of Wesdome. In accordance with the terms of the Arrangement, former Angus shareholders, excluding Wesdome, have received $0.62 in cash plus 0.0096 of a Wesdome share for each Angus common share previously held. “The acquisition of the prospective Angus property adjacent to our...

DCG sees significant momentum building for Q3/Q4 deal closings NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) — The  Dave Cantin Group (DCG), a leading mergers and acquisitions advisory company to retail automotive groups and their owners, today announced the successful closings of two California dealership transactions in a one-week period in June, a sign of growing momentum in the 2025 automotive buy/sell market and interest in California. DCG’s recent transactions include the sale of Audi West Covina and the strategic divestiture of Subaru of Hayward (formerly One Subaru). DCG’s experienced advisors facilitated the transactions, highlighting the company’s regional expertise, national reach, deep market insights and strategic advisory approach. “California is seeing an uptick of interest from the industry and there’s some pending legislation...

—Neopharmed Gentili will pay BioCryst $250 million upfront for the European assets and rights related to ORLADEYO, and up to $14 million in future milestones— —BioCryst plans to use proceeds to retire all remaining term debt, which will eliminate approximately $70 million of future interest payments over remaining life of the loan— —With this transaction, BioCryst expects to end 2027 with approximately $700 million in cash and no term debt (an increase of $400 million from prior 2027 net cash guidance)— RESEARCH TRIANGLE PARK, N.C., June 27, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has entered into a definitive agreement to sell its European ORLADEYO® (berotralstat) business to Neopharmed Gentili for up to $264 million. BioCryst plans to use the proceeds from the transaction...